CA Stock MarketDetailed Quotes
CYBN Cybin Inc
- 15.420
- +1.040+7.23%
15min DelayMarket Closed Nov 14 16:00 ET
308.29MMarket Cap-2028P/E (TTM)
16.000High14.800Low22.08KVolume15.250Open14.380Pre Close337.42KTurnover28.12052wk High0.11%Turnover Ratio19.99MShares9.25052wk Low-7.6EPS TTM308.29MFloat Cap152.000Historical HighLossP/E (Static)19.99MShs Float9.250Historical Low-9.5EPS LYR8.35%Amplitude--Dividend TTM1.10P/B1Lot Size--Div YieldTTM
About Cybin Inc Company
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.
Company Profile
SymbolCYBN
Company NameCybin Inc
Founded2016
MarketNEOE
Employees50
Fiscal Year Ends03-31
Address100 King Street West Suite 5600
CityToronto
CountryCAN
Zip CodeM5X 1C9
Phone+1 908 764-8385
Websitehttps://www.cybin.com
Company Executives
- Name
- Position
- Salary
- Douglas Drysdale
- Chief Executive Officer
- 834.17K
- Aaron Bartlone
- Chief Operation Officer
- 515.53K
- George Tziras
- Director and Chief Business Officer
- --
- Paul Glavine
- Director and Chief Growth Officer
- 624.00K
- Greg Cavers
- Chief Financial Officer
- 329.20K
- Gabriel Fahel
- Chief Legal Officer and Corporate Secretary
- --
- Alex Nivorozhkin
- Chief Scientific Officer
- --
- Eric So
- Director and President
- 624.00K
- Theresa Firestone
- Lead Independent Director
- 65.00K
- Mark Lawson
- Independent Director
- 50.00K
- Grant Froese
- Independent Director
- 50.00K
- Dr. Eric Hoskins
- Independent Director
- 50.00K
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data